AWHL

SEC source: 0001493152-26-045579 · ownership.xml · derivative · entry 1

Strahley John · CIK 0001875425 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,417

Underlying: Common Stock · 97,417 shares

Expires 2036-09-08

F1 · derivative.exercise_date: 48,708 shares vested on September 15, 2026. 24,354 shares vested on September 30, 2026. 24,355 shares will vest on October 15, 2026.

SEC source: 0001493152-26-033384 · ownership.xml · derivative · entry 1

Strahley John · CIK 0001875425 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2036-06-16

F1 · derivative.exercise_date: 18,750 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months.

SEC source: 0001493152-26-033814 · ownership.xml · derivative · entry 1

Strahley John · CIK 0001875425 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2036-06-16

F1 · shares: This form is being filed to correct the number of options awarded.

F2 · derivative.exercise_date: 17,500 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months.

SEC source: 0001493152-26-027952 · ownership.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 300,000

Underlying: Common Stock, par value $0.001 · 300,000 shares

Expires 2029-06-05

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

SEC source: 0001493152-26-027952 · ownership.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 4,046,051

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

SEC source: 0001493152-25-026078 · ownership.xml · derivative · entry 1

Wood Jane Pine · CIK 0001810531 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,592

Underlying: Common Stock · 135,592 shares

Expires 2035-12-02

SEC source: 0001493152-25-026076 · ownership.xml · derivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,178

Underlying: Common Stock · 185,178 shares

Expires 2035-12-02

SEC source: 0001493152-25-026074 · ownership.xml · derivative · entry 1

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,518

Underlying: Common Stock · 213,518 shares

Expires 2035-12-02

SEC source: 0001493152-25-026071 · ownership.xml · derivative · entry 1

Beausang Ellen · CIK 0002061533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,097

Underlying: Common Stock · 198,097 shares

Expires 2035-12-02

SEC source: 0001493152-25-026110 · ownership.xml · derivative · entry 1

Fraser John D · CIK 0001769195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,811

Underlying: Common Stock · 314,811 shares

Expires 2035-12-02

SEC source: 0001493152-25-026119 · ownership.xml · derivative · entry 1

Hundorfean Cynthia D · CIK 0002065631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,085

Underlying: Common Stock · 238,085 shares

Expires 2035-12-02

SEC source: 0001493152-25-014334 · ownership.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 833,333

Underlying: Common Stock, par value $0.001 · 833,333 shares

Expires 2030-09-17

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

SEC source: 0001493152-25-014334 · ownership.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 3,823,829

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

SEC source: 0001493152-25-014333 · ownership.xml · derivative · entry 3

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 491,985

Underlying: Common Stock, par value $0.001 · 41,667 shares

Expires 2030-09-17

SEC source: 0001493152-25-014333 · ownership.xml · nonDerivative · entry 1

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By HealthView Asset Management

Disclosed balance after: 375,697

SEC source: 0001493152-25-014233 · ownership.xml · derivative · entry 3

Fraser John D · CIK 0001769195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 981,549

Underlying: Common Stock, par value $0.001 · 12,292 shares

Expires 2030-09-17

SEC source: 0001493152-25-014233 · ownership.xml · nonDerivative · entry 1

Fraser John D · CIK 0001769195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 566,393

SEC source: 0001493152-26-026359 · ownership.xml · nonDerivative · entry 1

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 386,018

F1 · kind: The shares were acquired as payment to Dr. Cohen from another party in settlement of another property.

SEC source: 0001493152-26-026346 · ownership.xml · derivative · entry 3

Fraser John D · CIK 0001769195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,292

Underlying: Common Stock, par value $0.001 · 12,292 shares

Expires 2030-09-17

F1 · balance_after: This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

SEC source: 0001493152-26-026346 · ownership.xml · nonDerivative · entry 1

Fraser John D · CIK 0001769195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 566,393

SEC source: 0001493152-26-026345 · ownership.xml · derivative · entry 3

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common Stock, par value $0.001 · 41,667 shares

Expires 2030-09-17

F1 · balance_after: This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

SEC source: 0001493152-26-026345 · ownership.xml · nonDerivative · entry 1

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,906

F1 · balance_after: This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

SEC source: 0001641172-25-026580 · ownership.xml · derivative · entry 1

Hungerford Brian · CIK 0001981345 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-09-02

F1 · derivative.exercise_date: 25,000 shares will vest on September 2, 2026. The remaining shares will vest in equal monthly installments over the next 36 months.

SEC source: 0001641172-25-013811 · ownership.xml · derivative · entry 2

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-013811 · ownership.xml · nonDerivative · entry 1

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-013806 · ownership.xml · derivative · entry 2

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-013806 · ownership.xml · nonDerivative · entry 1

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-013804 · ownership.xml · derivative · entry 2

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-013804 · ownership.xml · nonDerivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-013801 · ownership.xml · derivative · entry 2

Beausang Ellen · CIK 0002061533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,843 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock

F3 · derivative.exercise_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-013801 · ownership.xml · nonDerivative · entry 1

Beausang Ellen · CIK 0002061533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,458

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025.

SEC source: 0001641172-25-014017 · ownership.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-014017 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-013935 · ownership.xml · derivative · entry 2

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,844 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-013935 · ownership.xml · nonDerivative · entry 1

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,734

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-012386 · ownership.xml · derivative · entry 1

Buhle Michael William · CIK 0002061539 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-05-22

F1 · derivative.exercise_date: The employee stock option will vest in forty-eight equal monthly amounts beginning January 30, 2025.

SEC source: 0001641172-25-013689 · ownership.xml · nonDerivative · entry 2

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 60,913

SEC source: 0001641172-25-013689 · ownership.xml · nonDerivative · entry 1

cohen Jeffrey k · CIK 0002071174 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 49,260

SEC source: 0001641172-25-002231 · ownership.xml · derivative · entry 2

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,156

Underlying: Common Stock · 5,156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002231 · ownership.xml · nonDerivative · entry 1

Parnell Winfred · CIK 0001979704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,053

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-002229 · ownership.xml · derivative · entry 2

Beausang Ellen · CIK 0002061533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,843

Underlying: Common Stock · 1,615 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock

F3 · derivative.exercise_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002229 · ownership.xml · nonDerivative · entry 1

Beausang Ellen · CIK 0002061533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025.

SEC source: 0001641172-25-002184 · ownership.xml · derivative · entry 2

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,937

Underlying: Common Stock · 5,938 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002184 · ownership.xml · nonDerivative · entry 1

Cavanaugh Stefanie L. · CIK 0001688530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-002183 · ownership.xml · derivative · entry 2

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,844

Underlying: Common Stock · 4,843 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002183 · ownership.xml · nonDerivative · entry 1

Ragard John Phillip · CIK 0002031593 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-002186 · ownership.xml · derivative · entry 2

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,437

Underlying: Common Stock · 8,438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002186 · ownership.xml · nonDerivative · entry 1

Herchuk Jannie Prestridge · CIK 0001973204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001641172-25-002185 · ownership.xml · derivative · entry 2

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002185 · ownership.xml · nonDerivative · entry 1

Fralick Celeste Rachelle · CIK 0001911051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.